Advertisement

Covid-19 cases in the US surpass 100 million, says report

According to health officials in China, Chinese cities are currently hit by the highly transmissible Omicron strains, mainly BA.5.2 and BF.7

Advertisement
|Dec 21, 2022, 16:20:45 IST

Washington: The number of Covid-19 cases registered in the US since the start of the pandemic in early 2020 exceeded a staggering 100 million, Johns Hopkins University has said, amid a sharp spike in caseloads globally and the WHO making a strong pitch for vaccination.Japan, the US, the Republic of Korea, Brazil and China have witnessed a sudden spike in coronavirus cases over the last week.US-based Johns Hopkins University in its latest update said that 100,003,837 coronavirus cases were reported in the country so far.The virus has also claimed the lives of 1,088,236 people in the US, it added. Meanwhile, close to 8,000 and 10,000 people die of COVID-19 every week, said Maria Van Kerkhove, an infectious disease epidemiologist who serves as the technical lead for the COVID-19 response team at the World Health Organisation (WHO).She told 'Science in 5' that the WHO target of vaccinating 70 per cent of the population in every country has not been achieved so far.

Advertisement

Vaccination against COVID-19 was "fundamental," she said. According to health officials in China, Chinese cities are currently hit by the highly transmissible Omicron strains, mainly BA.5.2 and BF.7.The novel coronavirus first emerged in the Chinese city of Wuhan in December 2019. Read all the Latest News, Trending NewsCricket News, Bollywood News,India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.

worldMore from World
Handpicked stories, in your inbox
Global stories. Indian perspective. Zero noise.
No Spam. Unsubscribe Any Time.
First Published:Dec 21, 2022, 16:20:45 IST
Advertisement
Advertisement
Trending Stories

Marco Rubio says he 'would expect India to be concerned' over Trump's pharma tariffs

US Secretary of State Marco Rubio acknowledged India's concerns over Donald Trump's proposed pharmaceutical tariffs, saying Washington is seeking greater domestic manufacturing while remaining engaged with New Delhi.
2 min read
Advertisement
Advertisement
Up Next